BACKGROUND: After radical cystectomy, patients are in a catabolic state because of postoperative stress response, extensive wound healing, and ileus. OBJECTIVE: To evaluate whether recovery can be improved with total parenteral nutrition (TPN) in patients following extended pelvic lymph node dissection (ePLND), cystectomy, and urinary diversion (UD). DESIGN, SETTING, AND PARTICIPANTS: We conducted a prospective, randomised, single-centre study of 157 consecutive cystectomy patients. INTERVENTION: Seventy-four patients (group A) received TPN during the first 5 postoperative days, with additional oral intake ad libitum. Eighty-three patients (group B) received oral nutrition alone. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome was the occurrence of postoperative complications. Secondary outcomes were time to recovery of bowel function, biochemical nutritional (serum albumin, serum prealbumin, serum total protein) and inflammatory (C-reactive protein) parameters, length of hospital stay, and costs attributed to the TPN. The Pearson χ(2) test was used for dichotomous variables; the Wilcoxon rank sum test was used for continuous variables. RESULTS AND LIMITATIONS: Postoperative complications occurred in 51 patients (69%) in group A and in 41 patients (49%) in group B (p=0.013), a difference resulting from group A having more infectious complications than group B (32% vs 11%; p=0.001). Serum prealbumin and serum total protein were significantly lower in group B on postoperative day 7 but not on postoperative day 12. Time to gastrointestinal recovery and length of hospital stay did not differ between the two groups. The costs for TPN were €614 per patient. A potential limitation is the use of a glucose-based parenteral nutrition without lipids. CONCLUSIONS: Postoperative TPN is associated with a higher incidence of complications, mainly infections, and higher costs following ePLND, cystectomy, and UD versus oral nutrition alone.
RCT Entities:
BACKGROUND: After radical cystectomy, patients are in a catabolic state because of postoperative stress response, extensive wound healing, and ileus. OBJECTIVE: To evaluate whether recovery can be improved with total parenteral nutrition (TPN) in patients following extended pelvic lymph node dissection (ePLND), cystectomy, and urinary diversion (UD). DESIGN, SETTING, AND PARTICIPANTS: We conducted a prospective, randomised, single-centre study of 157 consecutive cystectomy patients. INTERVENTION: Seventy-four patients (group A) received TPN during the first 5 postoperative days, with additional oral intake ad libitum. Eighty-three patients (group B) received oral nutrition alone. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome was the occurrence of postoperative complications. Secondary outcomes were time to recovery of bowel function, biochemical nutritional (serum albumin, serum prealbumin, serum total protein) and inflammatory (C-reactive protein) parameters, length of hospital stay, and costs attributed to the TPN. The Pearson χ(2) test was used for dichotomous variables; the Wilcoxon rank sum test was used for continuous variables. RESULTS AND LIMITATIONS: Postoperative complications occurred in 51 patients (69%) in group A and in 41 patients (49%) in group B (p=0.013), a difference resulting from group A having more infectious complications than group B (32% vs 11%; p=0.001). Serum prealbumin and serum total protein were significantly lower in group B on postoperative day 7 but not on postoperative day 12. Time to gastrointestinal recovery and length of hospital stay did not differ between the two groups. The costs for TPN were €614 per patient. A potential limitation is the use of a glucose-based parenteral nutrition without lipids. CONCLUSIONS: Postoperative TPN is associated with a higher incidence of complications, mainly infections, and higher costs following ePLND, cystectomy, and UD versus oral nutrition alone.
Authors: Peter Declercq; Gunter De Win; Frank Van der Aa; Elodie Beels; Beels Elodie; Lorenz Van der Linden; Hendrik Van Poppel; Ludo Willems; Willems Ludo; Isabel Spriet; Spriet Isabel Journal: Int J Clin Pharm Date: 2015-02-10
Authors: Hanan Goldberg; Chen Shenhar; Hadar Tamir; Roy Mano; Jack Baniel; David Margel; Daniel Kedar; David Lifshitz; Ofer Yossepowitch Journal: World J Urol Date: 2018-09-15 Impact factor: 4.226
Authors: Conrad M Tobert; Jill M Hamilton-Reeves; Lyse A Norian; Chermaine Hung; Nathan A Brooks; Jeff M Holzbeierlein; Tracy M Downs; Douglas P Robertson; Ruth Grossman; Kenneth G Nepple Journal: J Urol Date: 2017-03-09 Impact factor: 7.450
Authors: J Bertrand; N Siegler; T Murez; G Poinas; B Segui; D Ayuso; P Gres; L Wagner; R Thuret; P Costa; S Droupy Journal: World J Urol Date: 2013-12-21 Impact factor: 4.226